Sökning: onr:"swepub:oai:lup.lub.lu.se:1d2d69dd-2ce7-4bba-b4ef-1604476f8231" > Non-Lymphoma Hemato...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04038naa a2200601 4500 | |
001 | oai:lup.lub.lu.se:1d2d69dd-2ce7-4bba-b4ef-1604476f8231 | |
003 | SwePub | |
008 | 160401s2013 | |||||||||||000 ||eng| | |
024 | 7 | a https://lup.lub.lu.se/record/42041622 URI |
024 | 7 | a https://doi.org/10.1159/0003501652 DOI |
040 | a (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Lu, Mary4 aut |
245 | 1 0 | a Non-Lymphoma Hematological Malignancies in Systemic Lupus Erythematosus |
264 | c 2013-10-02 | |
264 | 1 | b S. Karger AG,c 2013 |
520 | a Objective: To describe non-lymphoma hematological malignancies in systemic lupus erythematosus (SLE). Methods: A large SLE cohort was linked to cancer registries. We examined the types of non-lymphoma hematological cancers. Results: In 16,409 patients, 115 hematological cancers [including myelodysplastic syndrome (MDS)] occurred. Among these, 33 were non-lymphoma. Of the 33 non-lymphoma cases, 13 were of lymphoid lineage: multiple myeloma (n = 5), plasmacytoma (n = 3), B cell chronic lymphocytic leukemia (B-CLL; n = 3), precursor cell lymphoblastic leukemia (n = 1) and unspecified lymphoid leukemia (n = 1). The remaining 20 cases were of myeloid lineage: MDS (n = 7), acute myeloid leukemia (AML; n = 7), chronic myeloid leukemia (CML; n = 2) and 4 unspecified leukemias. Most of these malignancies occurred in female Caucasians, except for plasma cell neoplasms (4/5 multiple myeloma and 1/3 plasmacytoma cases occurred in blacks). Conclusions: In this large SLE cohort, the most common non-lymphoma hematological malignancies were myeloid types (MDS and AML). This is in contrast to the general population, where lymphoid types are 1.7 times more common than myeloid non-lymphoma hematological malignancies. Most (80%) multiple myeloma cases occurred in blacks; this requires further investigation. (C) 2013 S. Karger AG, Basel | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
653 | a Systemic lupus erythematosus | |
653 | a Malignancy | |
653 | a Cancer | |
700 | 1 | a Bernatsky, Sasha4 aut |
700 | 1 | a Ramsey-Goldman, Rosalind4 aut |
700 | 1 | a Petri, Michelle4 aut |
700 | 1 | a Manzi, Susan4 aut |
700 | 1 | a Urowitz, Murray B.4 aut |
700 | 1 | a Gladman, Dafna4 aut |
700 | 1 | a Fortin, Paul R.4 aut |
700 | 1 | a Ginzler, Ellen M.4 aut |
700 | 1 | a Yelin, Edward4 aut |
700 | 1 | a Bae, Sang-Cheol4 aut |
700 | 1 | a Wallace, Daniel J.4 aut |
700 | 1 | a Jacobsen, Soren4 aut |
700 | 1 | a Dooley, Mary Anne4 aut |
700 | 1 | a Peschken, Christine A.4 aut |
700 | 1 | a Alarcon, Graciela S.4 aut |
700 | 1 | a Nived, Olau Lund University,Lunds universitet,Reumatologi och molekylär skelettbiologi,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Rheumatology,Section III,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)reum-oni |
700 | 1 | a Gottesman, Lena4 aut |
700 | 1 | a Criswell, Lindsey A.4 aut |
700 | 1 | a Sturfelt, Gunnaru Lund University,Lunds universitet,Reumatologi och molekylär skelettbiologi,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Rheumatology,Section III,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)reum-gst |
700 | 1 | a Dreyer, Lene4 aut |
700 | 1 | a Lee, Jennifer L.4 aut |
700 | 1 | a Clarke, Ann E.4 aut |
710 | 2 | a Reumatologi och molekylär skelettbiologib Sektion III4 org |
773 | 0 | t Oncologyd : S. Karger AGg 85:4, s. 235-240q 85:4<235-240x 1423-0232x 0030-2414 |
856 | 4 | u http://dx.doi.org/10.1159/000350165y FULLTEXT |
856 | 4 | u https://www.karger.com/Article/Pdf/350165 |
856 | 4 8 | u https://lup.lub.lu.se/record/4204162 |
856 | 4 8 | u https://doi.org/10.1159/000350165 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy